The in vitro antisickling and antioxidant effects of aqueous extracts Zanthoxyllum heitzii on sickle cell disorder by Nanfack Pauline et al.
Pauline et al. BMC Complementary and Alternative Medicine 2013, 13:162
http://www.biomedcentral.com/1472-6882/13/162RESEARCH ARTICLE Open AccessThe in vitro antisickling and antioxidant effects of
aqueous extracts Zanthoxyllum heitzii on sickle
cell disorder
Nanfack Pauline1, Biapa Nya Prosper Cabral2, Pieme Constant Anatole1*, Ama Moor Vicky Jocelyne1,3,
Moukette Bruno1 and Ngogang Yonkeu Jeanne1,3Abstract
Background: Several plant extracts from Rutaceae family are currently used to the management of sickle cell
disorder (SCD) in the African. Few reports have shown that extracts from Zanthoxyllum or Fagara genus
demonstrated anti-sickling property. This study investigates the in vitro antisickling and antioxidant properties of
extracts from Zanthoxyllum heitzii.
Methods: The sickling of red blood cells (RBCs) was induced using sodium metabisulfite (2%) followed by
treatment with extracts at different concentrations. The osmotic fragility tests permits to explore the effect of Z.
heitzii extracts on haemoglobin S solubility and sickle cells membrane stability. For each extract, qualitative
phytochemical tests were used to identify the presence of alkaloids, tannins, saponins, flavonoids, glycosides and
phenols, while some quantitative methods such as Folin, Ferric Reducing Antioxidant Power (FRAP) and diphenyl 1,
2 picryl hydrazyl (DPPH) were used to determine the antioxidant potential of these extracts.
Results: Sodium metabisulphite increased the sickling of RBCs from 29.62 to 55.46% during 2 h. Treatment of
sickling cells with extracts at different concentrations showed that a decrease of the percentage of sickling cells
was found in both induced and non induced sickling cells. The fruits extract of Z. heitzii demonstrated the best
anti-sickling property. The same extract at 250 μg/mL showed the best membrane cell stability compared to others.
All the extracts revealed an antioxidant and anti-radical activities although lesser compared to the standard.
Conclusion: The fruit extract of Z. Heitzii demonstrated the most significant antisickling effect with a potential for
use in the clinical management of SCD.
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Sickle-cell disorder (SCD), or sickle-cell anaemia is an
autosomal recessive genetic blood disorder with over-
dominance, characterized by red blood cells that assume
an abnormal, rigid, sickle shape and known to be one of
the diseases afflicting the population living mostly in
Africa, South America and Asia. It also occurs in other
ethnic groups, including people who are of Mediterra-
nean and Middle Eastern descent. In Cameroon, the* Correspondence: apieme@yahoo.fr
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reproduction in any medium, provided the orcarrier (AS/AC) rate is estimated between 20-25% while
the reported prevalence of SCD is between 2-3% [1],
and the disease is tending to become a public health
problem. As a genetic hereditary disease, no specific
drugs are yet available; however several treatments
have been investigated: (1) medullar transplantation is
not only expensive but also faces incompatibility prob-
lems; (2) various proposed drugs (hydroxyurea, pira-
cetam, calcium antagonists) tested against this disease
for inhibition of hemoglobin S polymerization inside
erythrocytes in order to increase the foetal hemoglobin
rate (HbF) or decrease the sickling are toxic especially
for a long time of use [2,3]. Considering all genetic dis-
orders, the debilitating effect, the cost of managing theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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produced from sickle RBCs than do normal RBCs
[4], research has been on-going to determine the effi-
cacy of the use of natural products such as medici-
nal plants, nutritional complement against sickle cell
disorder.
Some researchers have argued in favor of nutrition in
the management of sickle cell disorder [5]. The use of
traditional medicine can’t fade out in the treatment and
management of an array of diseases in the African
continent. Several studies demonstrated the anti-sickling
property of various extracts of Rutaceae family among
them Zanthoxyllum macrophyla and Fagara zanthoxy-
loides [6]. The roots of F. zanthoxyloides has been used
in folk medicine during sickle cell crisis and also there is
recent scientific reports its antisickling activity [7]. Vari-
ous molecules with anti-sickling property such as
divanilloylquinic acids, vanillic acid, p-hydroxy benzoic
acid, p-fluoro benzoic acid, 2-dihyroxymethyl benzoic
acid have been isolated from these plants [8,9].
Zanthoxylum heitzii (Aubrev. & Pellegr) or Fagara
heitzii is a plant from Rutaceae family. The representa-
tives of this family are distributed in 150 genera and
1500 species commonly found in tropical and warm
temperate regions of the world [10,11]. It is a family of
great importance due to its uses in perfumery, food
industry and management of diseases by the Traditional
Health Practitioners. Zanthoxyllum heitzii is one of the
cultivar of Fagara xanthozyloïdes found in the West
region of Cameroon. Its fruits is used as a spice for the
preparation of “nkui” and “Nah poh”, two dishes of
Cameoon [12]. It is also used as medicinal plant in
central Africa for the treatment of many diseases such
as cancer, syphilis, malaria, cardiac palpitations, uro-
genital affections [13,14]. Several molecules were
isolated from the stem bark of Z. heitzii among them,
two amides: heitziamide A and heitziamide B and two
phenylethanoids: heitziethanoid A and heitziethanoid
B and s trans-fagaramide, arnottianamide, iso-c fagarine,
iso-skimmianine, arctigenin methyl ether, savinin,
(+)-eudesmin, (+)-sesamin, lupeol, lupeone, b-sitosterol,
stigmasterol and stigmasterol-3-O-β-D-glucopyranoside
[15]. The bark of Z. heitzii is used as insecticides and re-
vealed some activities against cadiac affections [16].
Fagaricine, an aqueous extract formulation from root of Z.
heitzii was demonstrated as an immune-restorative phyto-
medicine to treat immunodeficiency [17].
However, no studies have yet been carried out to
investigate the antisickling and antioxidant properties
of the various parts of this plant. The present study
was performed with the aim to investigate the antio-
xidant property of Z. heitzii extracts, their effects on
the sickling cells and on erythrocyte membrane stabili-
zing activities.Methods
Plant materials and collection
Leaves, roots, fruits and stems barks of Zanthoxylum
heitzii (Rutaceae) collected on the 30 June 2010 at
Batchingou in the west of Cameroon and identified
under the reference number 1441/H.N.C at the National
Herbarium of Cameroon where the voucher specimen
was deposited.
Extraction of the plant material
Air-dried leaves, fruits, roots and stems of Z. heitzii were
ground and an aliquot (150 g) was extracted by macer-
ation (72 h) in 1.5 L of water as solvent. The same proced-
ure was repeated with residues and the mixture was
filtered and concentrated to dryness. The extract was
stored at 4°C in freeze - dried form and used for the study.
Collection of blood samples
The blood samples used in the evaluation of the anti-
sickling activity of the plant extracts in this study were
taken from patients between 19 and 31 years old known
to have sickle cell disease, attending the Central hospital
of Yaoundé . All these patients were confirmed regarding
their SS status using the electrophoresis test. The blood
samples were collected in the sodium EDTA tubes and
stored for the experiment. A written informed consent
was read and signed by all the patients participating in
the study. All the research procedures have received the
approval of Cameroon National Ethics Committee refer-
ence number 181/CNE/SE/2011 signed by Pr Lazare
Kaptue, the president of the committee.
Erythrocyte membrane stability activity
The osmotic fragility of erythrocytes measures the mem-
brane stabilizing effect of the extracts in osmotic stress/
hypotonic lysis incubation. To 10 mL reaction vessel
containing 4 mL of different concentrations (0.00 -
0.85%) of buffered saline with pH of 7.4, 1 ml of each
extract (250 μg/mL) and 0.05 ml SS-RBC blood were
added. The mixture was incubated at room temperature
(25°C) for 24 h and then centrifuged at 3000 rpm for
15 min. The optical density of the supernatant was read
at 540 nm against blank made of 0.85% buffered saline
concentration [18]. The mean corpuscular fragility (de-
termined from the concentration of saline causing 50%
haemolysis of the RBC) was obtained from a plot of lysis
(%) versus NaCl concentration.
Antisickling activity
In vitro induction of sickling
Five milliliters blood samples obtained from patients
were centrifuged at 5,000 rpm for 10 min in saline thrice
to obtain the RBC which were then resuspended in nor-
mal saline and used for the analysis according to the
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sions were mixed with 100 μL the presence of 2% so-
dium metabisulphite solution and incubated at 37°C.
The time course of the sickling of SS erythrocytes was
analyzed microscopically. The number of cell was
counted every one hour and the percentage of sickling
cells was calculated using the formula: (%) Sickling =
Number of sickling cells × 100/total cells.
In vitro anti-sickling activity of the extracts
A serial of different concentrations of aqueous extracts Z.
heitzii were prepared in the saline solution. For the assay
100 μL of SS-RBC pre-incubated with 2% Na2S2O5 was
added to 100 μl of solution of different extracts for final
concentration of 250, 500 and 1000 μg/mL. Each mixture
was incubated at 37°C for 2 h (time necessary to obtain
maximun sickling). After incubation, 10 μL of the mixture
was diluted 100 times. A drop of each sample was exam-
ined under the oil immersion light microscope and both
sickled cells and total cells were counted from five differ-
ent fields of view across the slide. For the negative control,
the solution containing the extract was replaced by the
saline solution. The percentage of sickling was calculated
using the formula: % of sickling = number of sickling
cells × 100/total cells.
For the reversibility assay, freshly collected HbSS
blood was diluted in 1:1 ratio with 0.9% normal saline
(negative control) or test solution containing different
extracts for final concentration of 250 μg/mL. The
experiment was followed as mentioned above and the
percentage of sickling cells was calculated.
Antioxidant and phytochemical screening
The antiradical activity of the plant extract was exam-
ined based on the scavenging effect of the stable DPPH
and hydroxyl free radical activity as well as the deter-
mination of power reducing and antioxidant capacity
antivities.
Scavenging Activity of DPPH Radical
The DPPH free radical scavenging assay was carried out
for the evaluation of the antioxidant activity [20]. Briefly,
in 3 mL of each diluted extract, 1 ml of methanol solu-
tion of DPPH 0.1 mM was added. The mixture was kept
in the dark at room temperature for 30 min and the ab-
sorbance was measured at 517 nm against a blank. The
following equation was used to determine the percentage
of the radical scavenging activity of each extract.
Percentage of radical scavenging activity = [(OD con-
trol - OD sample)/OD control] × 100 The IC50 value
(μg/mL) is the effective concentration at which DPPH
radicals were scavenged. by 50% and the value was
obtained by interpolation from linear regression analysis.Hydroxyl radical scavenging activity
The scavenging activity of the extract on hydroxyl rad-
ical was measured according to a previously described
method [21]. In 1.5 mL of each diluted extract, 60 μL of
FeCl3 (1 mM), 90 μL of 1,10- Phenanthroline (1 mM),
2.4 ml of 0.2 M phosphate buffer, pH 7.8 and 150 μL of
H2O2 (0.17 M) were added respectively. The mixture
was then homogenized and incubated at room temperature
for 5 min. The absorbance was read at 560 nm against the
blank. The percentage of the radical scavenging activity of
each extract was calculated from the equation below:
Percentage of radical scavenging activity = [(OD control - OD
sample)/OD control] × 100. The extract concentration
providing 50% inhibition (IC50) was calculated and ob-
tained by interpolation from linear regression analysis.
Reducing power assay
One milliliter of different concentration of extract (20-80-
120-240 μg/mL) diluted in distilled water was mixed with
2.5 mL of phosphate buffer (0.2 M, pH 6.6) and 2.5 mL of
potassium ferrocyanide (1%). The mixture was incubated
at 50°C for 20 min. Aliquot (2.5 mL) of trichloroacetic acid
(10%) was added to the mixture and centrifuged at
3000 rpm for 10 min. The upper layer of the solution
(2.5 mL) was mixed with 2.5 mL of distilled water and
0.5 mL of FeCl3 (0.1%). The increased absorbance was
measured at 700 nm against the blank indicates the in-
creasing of the reducing power [22].
Total antioxidant activity by ferric reducing antioxidant
power assay (FRAP)
The FRAP method was used to determine the total anti-
oxidant activity which measures the reduction of ferric
ion to the ferrous form in the presence of antioxidant
compounds [23]. The fresh FRAP reagent consist of
500 mL of acetate buffer (300 mM pH 3, 6), 50 mL of 2,
4, 6- Tri (2- pyridyl)-s-triazin (TPTZ) (10 mM), and
50 mL of FeCl3 · 6H2O (50 mM). For the assay, 75 μL of
each extract were mixed with 2 ml of FRAP reagent and
the optical density was read after 2 min at 593 nm
against the blank.
The standard procedure was used for screening
Z. heitzii extract for the presence of alkaloids, tannins,
saponins, flavonoids, glycosides and phenols [23].
Statistical analysis
Each test was performed in triplicate and the results were
expressed as mean ± standard deviation. The Kruskal-
Wallis non parametric test followed by a post hoc Dunnet
T3 (p < 0.05) was used to analyze the antioxidant capacity,
total phenols content as well as the radical scavenging ac-
tivity of each extract. The correlation between antioxidant
capacity and total phenols content was established using
the Pearson product moment correlation. The IC 50 was
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ware SPSS version 10.1 for Windows was used for statis-
tical analysis.Results
The yields of extraction are between 3.20 and 5.78%
depending on the part of the plant used (Table 1). The
extract of leaves from Z. heitzii has a higher extraction
yield compared to other. The result of induction of sick-
ling with sodium metabisulphite (2%) shows an increase
in sickling from 29.62 to 55.46% (Figure 1). Sodium
metabisulphite (2%) induced sickling of erythrocytes
with an average induction rate of 25.84% after 2 h of
incubation.
After treatment of red blood cells with extracts at dif-
ferent concentrations (250, 500 and 1000 μg/mL), a sig-
nificant decrease of the percentage of sickling cells was
observed (Figure 1). This percentage of sickling varied
from 38.78% at 1000 μg/mL to 44.05% at 250 μg/mL,
depending on the part of the plant and the concentra-
tion of each extract used. The fruit extract demonstrated
the highest decrease rate compared to others (Figure 1).
The percentage of sickling cells increased with the ex-
tract concentration, although was non significant and
non dose dependent for all extracts tested. The revers-
ibility of the sickling cells was noted through its signifi-
cant inhibition after 24 h of SS-RBC incubation with the
extracts of Z. heitzii at 250 μg/mL. The average rate
of this inhibition varied between 19.31 and 16.62% de-
pending on the extract (Figure 2). The fruit extract dem-
onstrated the highest decrease rate while the lowest was
that of the leaf. Regarding the erythrocyte osmotic fragil-
ity, this result showed a significant decrease of the per-
centage of hemolysis while increasing the concentration
of salt solution at 250 μg/mL of extracts (Figure 3). All
the extracts tested showed a lower hemolysis percentage
compared the control. Among the four extracts tested,
that of the fruit presented the most significant reduction








Fruits 5.62 8.17 ± 1.3 2.77 ± 0.4
Leaves 5.78 32.25 ± 0.9 2.09 ± 0.7
Root bark 3.41 8.8 ± 1.8 2.58 ± 0.3
Root wood 3.20 6.60 ± 0.5 2.15 ± 0.9
Vitamine C 12.61 ± 1.3 5.03 ± 0.3
Values are expressed as means ± Standard error (n = 3).the plant and then could have a better protective effect
of the erythrocyte membrane.
The anti-radical and antioxidant activities of the ex-
tracts using different methods showed that these activ-
ities vary depending on the part of the plant. The IC50 of
the extracts on DPPH and hydroxyl radicals varied from
6.60 to 32.25 μg/mL and from 9.2 to 3.5 μg/mL respect-
ively (Table 1). All the extracts have significantly
inhibited the hydroxyl radicals with IC50 less than 3 μg/
ml except the control. The noticeable of the reducing
power activity and the antioxidant properties of this
plant could serve as a significant indicator of the antioxi-
dant potential. The results of reducing power activity
showed that at 50 μg/mL all the extracts demonstrated a
weak activity (Table 1). The phytochemical screening of
these extracts revealed the presence of alkaloids, phe-
nols, mucilage and saponins. However, tannins and lipids
were not detected in these extracts. Flavonoids are found
in all extracts apart from that of the root.
Discussion
For the pharmacological discovery of novel drugs, the
primary essential information regarding the chemical
constituents are generally provided by the qualitative
phytochemical screening of plant extracts. In the present
study, qualitative tests for different extracts of Z. heitzii
showed the presence of several groups of bioactives mol-
ecules such as phenolics and alkaloids. Since the struc-
ture and chemical composition of plant parts affect the
ability of permeability, infiltration and solubilization of
groups of the bioactives compounds by the solvent, in
the same way, the quantitative and qualitative differences
between the phytochemical compounds in the extracts
influence their biological activities. The treatment of
erythrocytes with metabisulphite (2%) showed a signifi-
cant augmentation of sickling. Thus sodium metabisul-
phite creates hypoxic conditions for red blood cells
leading to the loss of the morphology and sickled eryth-
rocytes. In vitro deoxygenation of RBC by sodium
metabisulphite caused progressive aggregation andtract of Z. heitzii
ro antiradical and antioxidant of the extract
Antioxidant Properties (at 500 μg/mL of extract)
Reducing power
(Optical density at 700 nm)
Antioxidant potential
(mgEqBHT/g of extract)
0.12 ± 0.01 120 ± 2.4
0.11 ± 0.02 135 ± 1.5
0.12 ± 0.00 137 ± 3.5
0.12 ± 0.05 140 ± 5.3






















Concentration of extracts (µg/ml)
A B C D
Figure 1 Effect of sodium metabisulfite (2%) and extracts on sickling cells. Cl: Initial sickling percentage, HSE: Sickling percentage after
induction of with metabisulfite; (A): Fruits; (B): Leaves; (C): Root/bark; (D): Root wood.
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[24]. The process of gelation (polymerization) of hemo-
globin molecules increases the formation of sickling cells.
The sickle cell hemoglobin (HbS) is a product of a defect-
ive genetic code of hemoglobin molecule. The sickling
cells treated with extracts at different concentrations de-
creased as well as the naïve red blood cells used in the re-
versibility study when treated at 250 μg/mL. The activity
of the extracts could be due to the presence of some




























Figure 2 Effect of extracts on the reversibility of the sickling; In: Initia
after treatment with extract 250 μg/ml. (a): Fruits; (b): Leaves; (c): Root/screening of these extracts revealed compounds such as
phenols, flavonoids, alkaloids, saponins. The anti-sickling
activity could be linked to their ability either to inhibit
in vitro polymerization of haemoglobin or to some struc-
tural modification linked to the environment of haemoglo-
bin by the extracts [25].
Several researches have established that the capability of
a biomolecule to avoid in vitro polymerization depends on
one or combinations of the following options: (a) The ten-
dency and efficiency to bind to the complimentary contactb c d
 of extract
 In I (%)
l percentage of falciformation; I: Percentage of falciformation
bark; (d): Root wood.
Figure 3 Percentage of hemolysis of Sickling cells after treatment with 250 μg/ml of extract. (A): Fruits; (B): Leaves; (C): Root/bark;
(D): Root wood; HT: Total hemolysis.
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tion of amino acid residues that contribute to the three-
dimensional structures of HbS contact region and other
critical sites [27]; (c) Stabilization of the R (relaxed) state
of HbS molecule [3,24,27]. For sickle cell disorder, the
study of antioxidants especially in various antisickling
agents has a great importance because different anti-
sickling agents have different degrees of effect.
Studies demonstrated that antioxidant molecules were
found to be potent inhibitors of sickle cell haemoglobin
polymerization, and equally improved the oxidant status
of sickle erythrocytes [28-30]. This difference between
the anti-sickling activities noted in our study could
be attributed to different concentrations of the antioxi-
dant molecules such as polyphenol, flavonoids identified
in the different parts Z. heitzii. Also, the affinity of the
molecule with haemoglobin binding site would deter-
mine the degree of the active anti-sickling agents. Like
many proven anti-sickling agents, the most probable site
for binding is the heme pocket and the erythrocyte
membrane. The relation between antiradical and antioxi-
dant activities of the extracts and their antisickling activ-
ity could be explained by the ability of these extracts to
give hydrogen or electron atom to the iron molecule
of haemoglobin [31]. Antioxidants (scavengers of free
radicals) are believed to be major components of the
anti-sickling properties [32]. Plants which demonstrated
antioxidant property can be therapeutically useful [33].
Thus, it is believed that the higher the antioxidant prop-
erty of an antisickling agent, the higher its possible anti-
sickling effect, as this enables it reduce oxidative stressthat contributes to sickle cell crisis and increase the
membrane protection of the cells. Since the sickle cell
anemic individual undergoes oxidative stress at the onset
of crises, these plants can be used to mop up any free
radical released and so contribute to the effective man-
agement of the disorder. The antioxidant properties of
phenolics are important in scavenging and neutralization
of free radicals which can cause damage to cells if left in
the system. Thus the increased intake of dietary antioxi-
dants from Z. heitzii fruits may help to maintain an
adequate antioxidant defense status and consequently
contribute to the management of SCD.
Conclusion
The fruit extract of Z. heitzii demonstrated significant
antisickling and antioxidant properties. Therefore fur-
ther studies are indicated to establish these data in
transgenic mice models for human SCD. In addition, the
toxicity profiles and bioguided fractionation studies need
to be undertaken.
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